For instance, recent analysis of the CSP protein in the two WHO-approved malaria vaccines revealed the existence of monoclonal antibodies targeting two novel epitopes not currently included in these vaccines, offering avenues for improved vaccine design [52]. Here, DNAJC5 is linked to malaria.